Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedD-498-2013

Drug recall · June 5, 2013

Lisinopril Tablets recall

Why: Labeling: Label Error on Declared Strength: Incorrect strength on side display panel of label

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

Lisinopril Tablets, USP, 30 mg, Rx only, 100 tablets, NDC 65862-041-01 Manufactured for: Aurobindo Pharma USA Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad- 500 072 India

Lots / codes

Lot KP3012001-A Exp.12/13 Lot KP3012002-A Exp.12/13

Quantity
1776 bottles
Company
Aurobindo Pharma USA Inc, Plainsboro, NJ
Distribution
Nationwide
Initiated
April 9, 2013 · Voluntary: Firm initiated
Classified
May 30, 2013
Reported
June 5, 2013
Ended
January 23, 2014
How notified
Letter

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Lisinopril

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.